BlueCrest Capital Management’s Bruker Corporation 6.375% Series A Preferred Stock BRKRP Stock Holding History

BlueCrest Capital Management’s Portfolio BRKRP Stock Details BRKRP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.35M	Sell	5,240 -18,604	-78%	-$6.71M	0.08%	164
2026 Q1	$6.73M	Buy	23,844 +6,009	+34%	+$1.96M	0.4%	59
2025 Q4	$6.53M	Sell	17,835 -514	-3%	-$173K	0.2%	52
2025 Q3	$4.99M	Buy	+18,349	New	+$4.9M	0.11%	84

Other funds holding BRKRP

AAI

Aequim Alternative Investments Mill Valley, California $6.43B AUM 16.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

BlueCrest Capital Management's BRKRP Position: Q2 2026 in Review

BlueCrest Capital Management reduced its Bruker Corporation 6.375% Series A Preferred Stock (BRKRP) stake by 78% in Q2 2026, selling an estimated $6.71M and leaving 5,240 shares worth $2.35M. The position accounts for 0.08% of the portfolio, ranked #164.

BlueCrest Capital Management first reported a position in BRKRP in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.73M in Q1 2026. 35 funds tracked by Wall St. Rank hold BRKRP as of Q2 2026.

BlueCrest Capital Management held 5,240 shares of Bruker Corporation 6.375% Series A Preferred Stock worth $2.35M as of Q2 2026.
BlueCrest Capital Management sold 18,604 Bruker Corporation 6.375% Series A Preferred Stock shares in Q2 2026, an estimated $6.71M.
Bruker Corporation 6.375% Series A Preferred Stock made up 0.08% of BlueCrest Capital Management's portfolio in Q2 2026, its #164 holding.
BlueCrest Capital Management first reported a position in Bruker Corporation 6.375% Series A Preferred Stock in Q3 2025 and has held it in 4 quarters since.
BlueCrest Capital Management's Bruker Corporation 6.375% Series A Preferred Stock position peaked at $6.73M in Q1 2026.
35 funds tracked by Wall St. Rank held Bruker Corporation 6.375% Series A Preferred Stock as of Q2 2026.

Based on BlueCrest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.